LEADER 03477nam  2200589Ia 450 
001 9910830684303321
005 20170815152910.0
010   $a1-280-83870-1
010   $a9786610838707
010   $a0-470-05959-1
010   $a0-470-05958-3
035   $a(CKB)1000000000357108
035   $a(EBL)291030
035   $a(SSID)ssj0000244272
035   $a(PQKBManifestationID)11210408
035   $a(PQKBTitleCode)TC0000244272
035   $a(PQKBWorkID)10164999
035   $a(PQKB)10772566
035   $a(MiAaPQ)EBC291030
035   $a(PPN)243331355
035   $a(OCoLC)86240715
035   $a(EXLCZ)991000000000357108
100   $a20070202d2007      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aSepsis$b[electronic resource] $enew insights, new therapies
210   $aChichester, UK ;$aHoboken, NJ $cWiley$d2007
215   $a1 online resource (303 p.)
225 1 $aNovartis Foundation symposium ;$v280
300   $a"Symposium on Sepsis: new insights, new therapies, held at the Novartis Foundation, London, 14-16 February, 2006."--Contents.
311   $a0-470-02798-3 
320   $aIncludes bibliographical references and indexes.
327   $aSepsis: New Insights, New Therapies; Contents; Chair's introduction; DISCUSSION; Strategies to modulate cellular energetic metabolism during sepsis; DISCUSSION; Immunostimulation is a rational therapeutic strategy in sepsis; DISCUSSION; Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis; DISCUSSION; Modulating neutrophil apoptosis; DISCUSSION; HMGB1 as a potential therapeutic target; DISCUSSION; Poly (ADP-ribose) polymerase activation and circulatory shock; DISCUSSION; Choosing the right substrate; DISCUSSION; Inhibiting glycogen synthase kinase 3b in sepsis
327   $aDISCUSSIONEthyl pyruvate: a novel treatment for sepsis; DISCUSSION; GENERAL DISCUSSION I; Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models; DISCUSSION; The hypothalamic pituitary adrenal axis in sepsis; DISCUSSION; Modulating the endocrine response in sepsis: insulin and blood glucose control; DISCUSSION; The neuronal strategy for inflammation; DISCUSSION; Beta-blockade in burns; DISCUSSION; System interactions; DISCUSSION; Protecting the permeability pore and mitochondrial biogenesis; DISCUSSION; Contributor index; Subject index
330   $aSepsis: New Insights, New Therapies brings together contributions from an international group of experts in diverse fields to consider how the various pathways implicated in early and late sepsis interact, with a particular emphasis on novel concepts and potential new therapeutic approaches. Topics covered include adaptive immunity, inflammation, neuroendocrinology, bioenergetics and metabolism. Several chapters in the latter half of the book are particularly concerned with treatment strategies involving modulation of the neuroendocrine response. Addresses the frequent, b
410  0$aNovartis Foundation symposium ;$v280.
606   $aSepticemia$vCongresses
606   $aBlood$xDiseases$vCongresses
615  0$aSepticemia
615  0$aBlood$xDiseases
676   $a616.944
712 02$aNovartis Foundation.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830684303321
996   $aSepsis$91757179
997   $aUNINA